Ariane Brusselmans

Opening Ceremony

• Vicenzanephrocourses: Thirty years in three minutes – C. Ronco
• Lazaro Gotloib Memorial Lecture: Past, present and future of PD – N. Lameire

Session 1: Summit on PD around the world

• The International Society of Nephrology – G.Remuzzi
• The European Renal Association ERA-EDTA – R. Vanholder
• The EUROPD- A. Joerres
• The International Society of Peritoneal Dialysis – I. Teitelbaum
• The ISPD – Asian Chapter – K.S. Nayak
• The American Society of Nephrology – J. Burkart
• The Chinese Society of Nephrology – Z.H. Liu
• The European Society of Pediatric Nephrology – E. Verrina
• The Latin American Society of Nephrology – R. Correa-Rotter
• The Italian Society of Nephrology – G. Capasso

Session 2: Research in Peritoneal Dialysis – the last and next thirty years

• Peritoneal Membrane Morphology – G. Garosi
• Peritoneal transport – B. Rippe
• Peritoneal Membrane biology – O. Devuyst
• Peritoneal Dialysis solutions – A. Joerres
• Treatment modalities and targets – J. Burkart
• PD in pts with abdominal and thoracic abnomalities – M. Misra

Session 3: Peritoneal Dialysis Solutions

• Biocompatibility of PD solutions – R. Mehrotra
• PD solutions and nutritional status – C.Verger
• 20 years of bicarbonate solutions – M. Feriani
• Alternative dialysis strategies with icodextrin – I. Teitelbaum
• Are current solutions adequate for pediatric use? – E. Verrina

Session 4: New challenges for PD and home therapies

Session 4b: Practical Issues in Peritoneal Dialysis

• The financial benefits of home therapies – R. Greenwood
• When and how to start peritoneal dialysis – M. Schreiber
• The Brazilian PD Study (BRAZPD) – J. Divino
• Outcomes: PD vs HD – R. Mehrotra
• Hypogonadism, wasting and ESA resistance – P. Stenvinkel

 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 

• Getting the right patient on the right treatment – M. Perez Fontan
• Barriers and opportunities of home therapies – N. Lameire
• How to avoid technique failure in PD – J.P. Ryckelynck
• Ultrafiltration failure: diagnosis & management – W. Van Biesen

Session 5: Telemedicine and e-Health on PD

• Computer assisted Data Collection and management – C. Ronco
• Telemedicine in peritoneal dialysis – M. Rosner
• e-Health: remote health care models in PD – W. Van Biesen
• Cardiovascular complications in PD patients – D.G Struijk
• Remote monitoring of PD in special locations – K.S. Nayak

Session 6: Lipid disorders, inflammation and anemia

• Dialysis option for the very elderly – M. Rosner
• Anemia management in PD patients – F. Locatelli
• Maximising EPO response: Iron strategies – K.S. Nayak
• Lipid disorders in uremia & dialysis – G. Bakris
• Statins and lipid lowering strategies in PD – O. Heimbürger 

Session 7: CKD-MBD and Inflammation Management in PD

• Which phosphate binder in PD patients – M. Cozzolino
• Use of VDR Activitations in PD – J. Bover
  
• Calcimimetrics in PD patients – P. Messa
• Factors affecting loss of residual functions in Dialysis – N. Levin
• New therapeutic options for inflammation in PD – D. Warrock

Session 8: Fluid overload and cardiovascular

Session 8b: Practical Issues in Peritoneal Dialysis 2

• Fluid homeostasis in PD – J. Teixodo
• BIVA + BNP in PD patients – C. Crepaldi
• PD in heart failure patients – M. Schreiber
• Role of PD in Cardio-Renal patients – A. Rodrigues

 
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

• PD access: what’s the best approach? – M. Riella
• Catheter placement techniques – W. Van Biesen
• Infectious complications: treatment considerations – A Joerres
• Adequacy in peritoneal dialysis – J.P. Ryckelynck
• Setting up research in PD – J. Witowski

Session 9: Controversies

• Do we need PD guidelines? Yes, They are useful – N. Lameire
• Do we need PD guidelines? No, they are dangerous – R. Amerling
• Take patients off PD after 7 years to prevent EPS? Yes, we must! – F. Finkelstein
• Take patients off PD after 7 years to prevent EPS? No, there is no need – E. Brown

Session 10: Peritoneal Dialysis Technology

• Wearable technology: where are we? – C. Ronco
• Continuous Flow PD – R. Amerling
• 1 day HD and 5 days PD: does it make sense?  – J. Burkart
• Time between catheter insertion and use – I. Teitelbaum
• PD membrane evaluation in clinical practice – R. Krediet

Session 11: Peritonitis and other clinical outcomes

• Today’s approaches to prevent peritonitis – B. Piraino
• Transplant outcome and dialysis modality- I. Teitelbaum
• Pancreas/Kidney transplant in PD patients – M. Schreiber
• Early diagnosis of Peritonitis: the case of NGAL – F.K. Martino
• Prognostic factors for peritonitis outcome – D.G. Struijk
• How to improve the care of diabetic patient on PD – M. Misra
• How to select among dialysis option – A. Mooney